IDIQ for CDER GDUFA research program for brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics.
Type: Forecast
Overview
Description
The Center for Drug Evaluation and Research (CDER), requires Pharmaceutical Manufacturer/Supplier to provide brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics. A Single award IDIQ contract is anticipated to provide multiple types of pharmaceutical drugs (approximately 75 types) to support the GDUFA research program.
Est. Value
Min: $3,000,000
Max: $7,000,000
Max: $7,000,000
Est. Award Date
46235
Set Aside
To be determined
Forecast Type
New
Forecast Source
Health and Human Services
Food and Drug Administration is forecasted to issue a new procurement for IDIQ for CDER GDUFA research program for brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics. around 46235 worth up to $7,000,000.
Agency
Source Level 1 Agency
Health and Human Services
Source Level 2 Agency
Food and Drug Administration
Source Level 3 Agency
FDA
Contacts
Potential Bidders and Partners
Similar Active Opportunities
Additional Detail
Date Published
5/28/26